Polaris Group Announced the Acquisition of Genovior
TAIPEI, Taiwan and SAN DIEGO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Polaris Group (The Company, TWSE:6550) announced that its board approved to increase the...
Source: globenewswire.com
Adi Peg 20 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Adi Peg 20. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Adi Peg 20 Today - Breaking & Trending Today
Polaris begins rolling BLA for ADI-PEG 20 for pleural mesothelioma
Polaris Pharmaceuticals Inc. has submitted the first part of its rolling BLA to the FDA for lead product, ADI-PEG 20, for systemic treatment of patients with malignant pleural mesothelioma with non-epithelioid histology in combination with a platinum agent and pemetrexed. The BLA is supported by the pivotal phase III Atomic study in which pegargiminase (pegylated arginine deiminase/ADI-PEG 20) met the primary endpoint of a statistically significant improvement in overall survival and the secondary endpoint of a significant improvement in progression-free survival in patients with malignant ple...
Source: bioworld.com